Mehrdad A. Estiar
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
-
- Neurological diseases and metabolism 8
- Parkinson's Disease Mechanisms and Treatments 4
-
- Neurogenetic and Muscular Disorders Research 8
-
- Neurological diseases and metabolism 8
- Parkinson's Disease Mechanisms and Treatments 4
-
- Circular RNAs in diseases 4
-
- Hereditary Neurological Disorders 10
-
- Cancer-related Molecular Pathways 3
- Co-authors
- Ebrahim SakhiniaMahshid HashemkhaniNavid SolatiMichael R. HamblinE.A. MohamedAmir GhasemiMahdiar TaheriMahdi Karimi
- Cited by
- Cancer ResearchNeurologyGenetics
- Partner nations
- IranCanadaUnited States
In The Last Decade
Mehrdad A. Estiar
53 papers receiving 869 citations
Peers
Comparison fields: 5 of 109
- Cancer Research 133
- Neurology 61
- Genetics 61
- Neurology 84
- Molecular Biology 362
Countries citing papers authored by Mehrdad A. Estiar
This map shows the geographic impact of Mehrdad A. Estiar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehrdad A. Estiar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehrdad A. Estiar more than expected).
Fields of papers citing papers by Mehrdad A. Estiar
This network shows the impact of papers produced by Mehrdad A. Estiar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehrdad A. Estiar. The network helps show where Mehrdad A. Estiar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mehrdad A. Estiar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 14 | |
| 4 | 2021 | 5 | |
| 5 | 2021 | 14 | |
| 6 | 2021 | 7 | |
| 7 | 2021 | 34 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 27 | |
| 10 | 2021 | 6 | |
| 11 | 2020 | 29 | |
| 12 | 2020 | 18 | |
| 13 | 2018 | 34 | |
| 14 | 2016 | 23 | |
| 15 | 2016 | 4 | |
| 16 | 2016 | 20 | |
| 17 | 2016 | 9 | |
| 18 | 2015 | 98 | |
| 19 | 2014 | 14 | |
| 20 | 2013 | 39 |
About Mehrdad A. Estiar
Mehrdad A. Estiar is a scholar working on Genetics, Neurology and Cellular and Molecular Neuroscience, having authored 54 papers that have together received 880 indexed citations. Recurring topics across this work include Hereditary Neurological Disorders (10 papers), Neurological diseases and metabolism (8 papers), Neurogenetic and Muscular Disorders Research (8 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Cancer Research (133 citations), Neurology (61 citations) and Genetics (61 citations). Mehrdad A. Estiar has collaborated with scholars based in Iran, Canada and United States. Frequent co-authors include Ebrahim Sakhinia, Mahshid Hashemkhani, Navid Solati, Michael R. Hamblin, E.A. Mohamed, Amir Ghasemi, Mahdiar Taheri, Mahdi Karimi, Amir Reza Aref and Mohammad Sadegh Amiri. Their work appears in journals such as Gene, European Journal of Pharmacology and Movement Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.